
IRT
Randomization, drug supply management, and direct-to-patient capabilities for streamlined clinical trial execution.
Overview
IQVIA's Interactive Response Technology (IRT) is a clinical trial management system designed to support randomization, drug supply management, and direct-to-patient capabilities across studies of varying complexity. It is intended for sponsors, contract research organizations, and clinical operations teams seeking to streamline trial execution, reduce supply waste, and adapt to evolving study requirements without delays.
The platform supports both traditional site-based trials and decentralized or hybrid study models, offering flexibility in how investigational products are allocated and delivered to patients. IRT integrates within IQVIA's broader clinical technology ecosystem, connecting with other trial management tools to support end-to-end study operations.
Randomization Capabilities
- Supports advanced randomization methodologies to ensure appropriate patient allocation across treatment arms
- Designed to handle complex randomization schemes across multi-site, multi-country studies
- Enables faster study execution through automated randomization workflows
Drug Supply Management
- Manages investigational product inventory across clinical trial sites
- Tracks drug supply levels to help prevent shortages or overstocking at individual sites
- Supports forecasting and resupply processes to reduce waste and optimize distribution
- Accommodates flexible supply strategies aligned with study design requirements
Direct-to-Patient Capabilities
- Supports delivery of investigational products directly to patients, enabling decentralized and hybrid trial models
- Facilitates patient-centric study execution by reducing the need for site visits related to drug dispensing
- Designed to work alongside patient engagement tools within the IQVIA clinical suite
Study Flexibility and Execution
- Built to accommodate protocol amendments and changes in study design without significant system reconfiguration delays
- Supports studies across multiple phases, from early phase through Phase IIb/III trials
- Designed for global deployment across multi-regional studies
IQVIA IRT is part of the broader IQVIA clinical products portfolio, which includes eCOA, patient engagement tools, site management solutions, and clinical data analytics. It is positioned to integrate with these adjacent systems to support connected, data-driven trial management across the full study lifecycle.